These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 18040274)

  • 1. Evaluation of 18F-2-deoxy-2-fluoro-glucose positron emission tomography for gastric cancer screening in asymptomatic individuals undergoing endoscopy.
    Shoda H; Kakugawa Y; Saito D; Kozu T; Terauchi T; Daisaki H; Hamashima C; Muramatsu Y; Moriyama N; Saito H
    Br J Cancer; 2007 Dec; 97(11):1493-8. PubMed ID: 18040274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of whole-body cancer screening using 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography: a preliminary report.
    Terauchi T; Murano T; Daisaki H; Kanou D; Shoda H; Kakinuma R; Hamashima C; Moriyama N; Kakizoe T
    Ann Nucl Med; 2008 Jun; 22(5):379-85. PubMed ID: 18600415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in gastric carcinoma: relation to histological subtypes, depth of tumor invasion, and glucose transporter-1 expression.
    Yamada A; Oguchi K; Fukushima M; Imai Y; Kadoya M
    Ann Nucl Med; 2006 Nov; 20(9):597-604. PubMed ID: 17294670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance profile of a FDG-PET cancer screening program for detecting gastric cancer: results from a nationwide Japanese survey.
    Minamimoto R; Senda M; Jinnouchi S; Terauchi T; Yoshida T; Inoue T
    Jpn J Radiol; 2014 May; 32(5):253-9. PubMed ID: 24562822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of (18)F-FDG PET/CT as a postoperative surveillance imaging modality for asymptomatic advanced gastric cancer patients.
    Lee DY; Lee CH; Seo MJ; Lee SH; Ryu JS; Lee JJ
    Ann Nucl Med; 2014 Oct; 28(8):789-95. PubMed ID: 24965850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinically unrecognized pulmonary aspiration during gastrointestinal endoscopy with sedation: a potential pitfall interfering the performance of 18F-FDG PET for cancer screening.
    Hsieh TC; Wu YC; Ding HJ; Wang CH; Yen KY; Sun SS; Yeh JJ; Kao CH
    Eur J Radiol; 2011 Dec; 80(3):e510-5. PubMed ID: 21439750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [18F]Fluoro-2-deoxy-D-glucose positron emission tomography detects gastric carcinoma in an early stage in an asymptomatic E-cadherin mutation carrier.
    van Kouwen MC; Drenth JP; Oyen WJ; de Bruin JH; Ligtenberg MJ; Bonenkamp JJ; van Krieken JH; Nagengast FM
    Clin Cancer Res; 2004 Oct; 10(19):6456-9. PubMed ID: 15475432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of (18)F-2-deoxy-2-fluoro-glucose accumulation in the stomach on positron emission tomography.
    Takahashi H; Ukawa K; Ohkawa N; Kato K; Hayashi Y; Yoshimoto K; Ishiyama A; Ueki N; Kuraoka K; Tsuchida T; Yamamoto Y; Chino A; Uragami N; Fujisaki J; Igarashi M; Fujita R; Koyama M; Yamashita T
    Ann Nucl Med; 2009 Jun; 23(4):391-7. PubMed ID: 19399579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18F-FDG PET/CT role in staging of gastric carcinomas: comparison with conventional contrast enhancement computed tomography.
    Altini C; Niccoli Asabella A; Di Palo A; Fanelli M; Ferrari C; Moschetta M; Rubini G
    Medicine (Baltimore); 2015 May; 94(20):e864. PubMed ID: 25997066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity of 2-[
    Sekiguchi M; Kakugawa Y; Terauchi T; Matsumoto M; Saito H; Muramatsu Y; Saito Y; Matsuda T
    J Gastroenterol; 2016 Dec; 51(12):1122-1132. PubMed ID: 27021493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of gastric cancer using 18F-FLT PET: comparison with 18F-FDG PET.
    Kameyama R; Yamamoto Y; Izuishi K; Takebayashi R; Hagiike M; Murota M; Kaji M; Haba R; Nishiyama Y
    Eur J Nucl Med Mol Imaging; 2009 Mar; 36(3):382-8. PubMed ID: 18985344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of 18F-FDG PET/CT in the evaluation of gastric cancer recurrence after curative gastrectomy.
    Lee JE; Hong SP; Ahn DH; Jeon TJ; Kang MK; Kwon CI; Ko KH; Hwang SG; Park PW; Rim KS
    Yonsei Med J; 2011 Jan; 52(1):81-8. PubMed ID: 21155039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of lymph node metastases using 18F-FDG PET in patients with advanced gastric cancer.
    Kim SK; Kang KW; Lee JS; Kim HK; Chang HJ; Choi JY; Lee JH; Ryu KW; Kim YW; Bae JM
    Eur J Nucl Med Mol Imaging; 2006 Feb; 33(2):148-55. PubMed ID: 16228236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography for gastric cancer.
    Mochiki E; Kuwano H; Katoh H; Asao T; Oriuchi N; Endo K
    World J Surg; 2004 Mar; 28(3):247-53. PubMed ID: 14961197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of gastric distention with additional water in differentiating locally advanced gastric carcinomas from physiological uptake in the stomach on 18F-fluoro-2-deoxy-D-glucose PET.
    Kamimura K; Nagamachi S; Wakamatsu H; Fujita S; Nishii R; Umemura Y; Ogita M; Komada N; Sakurai T; Inoue T; Fujimoto T; Nakajo M
    Nucl Med Commun; 2009 Jun; 30(6):431-9. PubMed ID: 19352209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective evaluation of the utility of 2-deoxy-2-[(18) F]fluoro-D-glucose positron emission tomography and computed tomography in staging locally advanced gastric cancer.
    Smyth E; Schöder H; Strong VE; Capanu M; Kelsen DP; Coit DG; Shah MA
    Cancer; 2012 Nov; 118(22):5481-8. PubMed ID: 22549558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic performance of FDG PET/CT for surveillance in asymptomatic gastric cancer patients after curative surgical resection.
    Lee JW; Lee SM; Son MW; Lee MS
    Eur J Nucl Med Mol Imaging; 2016 May; 43(5):881-888. PubMed ID: 26611426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of vesicant 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) in gastric malignancies.
    Tian J; Chen L; Wei B; Shao M; Ding Y; Yin D; Yao S
    Nucl Med Commun; 2004 Aug; 25(8):825-31. PubMed ID: 15266178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of ¹⁸F 2-fluoro-2-deoxyglucose positron emission tomography in upper gastrointestinal malignancies.
    Smyth EC; Shah MA
    World J Gastroenterol; 2011 Dec; 17(46):5059-74. PubMed ID: 22171140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-Deoxy-2-[F-18]fluoro-D-glucose positron emission tomography/computed tomography in the management of melanoma.
    Iagaru A; Quon A; Johnson D; Gambhir SS; McDougall IR
    Mol Imaging Biol; 2007; 9(1):50-7. PubMed ID: 17051322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.